Comparison of the mitogenic activity of human epidermal growth factor 1-53 and epidermal growth factor 1-48 in vitro and in vivo

Clinical Science

Volumn 91, Issue 4, 1996, Pages 503-507

  Goodlad, R A ^a   Boulton, R ^b   Playford, R J ^c,d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cell proliferation; Epidermal growth factor; Gastrointestinal tract; Intravenous (parenteral) nutrition; Urogastrone

Indexed keywords

GAMMA UROGASTRONE; RECOMBINANT EPIDERMAL GROWTH FACTOR; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; LARGE INTESTINE; LIVER CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; TOTAL PARENTERAL NUTRITION;

EID: 0029838611     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0910503     Document Type: Article

References (27)

1. Gregory H. In vivo aspects of urogastrone - epidermal growth factor. J Cell Sci 1985; 3 (Suppl.): 11-17.
2. Weaver LT, Walker WA. Epidermal growth factor and the developing human gut. Gastroenterology 1988; 94: 845-7.
3. Bell G, Fong NM, Stempien NM, et al. Human EGF precursor: cDNA sequence, expression in vitro and gene organisation. Nucleic Acids Res 1986; 14: 8427-46.
4. Campbell ID, Baron M, Cooke RM, et al. Structure function relationship in epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α). Biochem Pharmacol 1990; 40: 35-40.
5. Joh T, Itoh M, Katsumi K, et al. Physiological concentrations of human epidermal growth factor; Use of a sensitive enzyme immunoassay. Clin Chim Acta 1986; 158: 81-90.
6. Playford RJ, Marchbank T, Calnan DP, et al. Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice. Gastroenterology 1995; 108: 92-101.
7. Playford RJ, Woodman AC, Clark P, et al. Effect of luminal growth factor preservation on intestinal growth. Lancet 1993; 341: 843-8.
8. Gregory H, Thomas CE, Young J, Willshire IR, Garner A. The contribution of the C-terrnmal undecapeptide sequence of urogastrone-epidermal growth factor to its biological activity. Regul Pept 1988; 22: 217-26.
9. Skov OP, Nexo E, Poulsen SS, Hansen HF, Kirkegaard P. Renal origin of rat urinary epidermal growth factor. Regul Pept 1984; 10: 37-45.
10. Koldovsky O, Britton J, Davis D, et al. The developing gastrointestinal tract and milk-borne epidermal growth factor. Adv Exp Med Biol 1991; 310: 99-105
11. Basson MD, Modlin IM, Flynn SD, Jena BP, Madri JA. Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins, and pharmacologic agents in an in vitro model of mucosal healing. Surgery 1992; 112: 299-307.
12. Goodlad RA, Wilson TJ, Lenton W, Gregory H, McCullagh KG, Wright NA. Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut 1987; 28: 573-82.
13. Goodlad RA, Wright NA. Growth control factors in the gastrointestinal tract. Bailliere's Clin Gastroenterol 1990; 4: 97-119.
14. Araki F, Nakamura H, Nojima NKT, Sakamoto S. Stability of recombinant epidermal growth factor in various solutions. Chem Pharm Bull 1989; 37: 404-6.
15. Guglietta A, Lesch CA. Effect of h-EGF and h-EGF 1-48 on histamine-stimulated gastric-acid secretion in rats and monkeys. J Physiol (Paris) 1993; 87: 343-7.
16. Selden C, Hodgson HJF. Further characterisation of hepatotropin, a high molecular weight hepatotrophic factor in rat serum. J Hepatol 1989; 9: 167-76.
17. Goodlad RA. Microdissection-based techniques for the determination of cell proliferation in gastrointestinal epithelium: application to animal and human studies. In: Celis JE, ed. Cell biology: a laboratory handbook. New York: Academic Press, 1994: 205-16.
18. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature (London) 1990; 343: 82-5.
19. Goodlad RA, Wright NA. Epidermal growth-factor and transforming growth-factor-alpha actions on the gut. Eur J Gastroenterol Hepatol 1995; 7: 928-32.
20. Skov OP, Poulsen SS, Therkelsen K, Nexo E. Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology 1986; 90: 911-17.
21. Konturek SJ. Mechanisms of gastroprotection. Scand J Gastroenterol 1990; 174 (Suppl.): 15-28.
22. Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 1991; 13: S21-34.
23. Sullivan PB, Brueton MJ, Tabara Z, Goodlad RA, Lee CY, Wright NA. Epidermal growth factor in necrotising enteritis. Lancet 1991; 338: 53-4.
24. Walker-Smith JA, Phillips AD, Walford N, et al. Intravenous epidermal growth factor/urogastrone increases small intestinal cell proliferation in congenital microvillous atrophy. Lancet 1985; 11: 1239-40.
25. Itoh M, Matsuo Y. Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study. J Gastroenterol Hepatol 1994; 9: S78-83.
26. Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerisation. Trends Biol Sci 1994; 19: 459-63.
27. Playford RJ, Boulton R, Ghatei MA, Bloom SR, Wright NA, Goodlad RA. Comparison of the effects of TGFα and EGF on gastrointestinal proliferation and hormone release. Digestion (In press).